Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2022
∙
SAGE
Should an off-label , permissive one-dose HPV vaccine schedule for use in routine and/or multi-age cohort (MAC) catch up strategies be recommended?
2022
∙
SAGE
Human papillomavirus vaccines: WHO position paper, December 2022
2022
Introduction of Hepatitis B Birth Dose Vaccination in Africa: A Toolkit for National Immunization Technical Advisory Groups
2022
∙
TITAG
Recommendation on nOPV2 vaccine
2022
∙
TITAG
Introduction of malaria vaccine RTS,S/AS01 for use among children in Tanzania populace
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
ACIP
Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register